IR Biosciences Holdings Inc.
IRBS · OTC
12/31/2010 | 12/31/2009 | 12/31/2008 | 12/31/2007 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $269 | $559 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2,860 | $3,126 | $5,024 | $5,516 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2,860 | $3,126 | $5,024 | $5,516 |
| Operating Income | -$2,860 | -$3,126 | -$5,024 | -$5,516 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$2,423 | -$3,336 | -$783 | $63 |
| Pre-Tax Income | -$5,282 | -$6,463 | -$5,807 | -$5,453 |
| Tax Expense | -$4 | $0 | $0 | $11 |
| Net Income | -$5,278 | -$6,463 | -$5,807 | -$5,464 |
| % Margin | – | – | – | – |
| EPS | -0.31 | -0.49 | -0.49 | -0.5 |
| % Growth | 36.7% | 0% | 2% | – |
| EPS Diluted | -0.31 | -0.49 | -0.49 | -0.5 |
| Weighted Avg Shares Out | 16,831 | 13,182 | 11,824 | 11,422 |
| Weighted Avg Shares Out Dil | 16,831 | 13,182 | 11,824 | 11,422 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1,707 | $2,163 | $783 | $0 |
| Depreciation & Amortization | $8 | $14 | $17 | $15 |
| EBITDA | -$3,568 | -$4,286 | -$5,007 | -$5,501 |
| % Margin | – | – | – | – |